T-Pred FDA Approval Status
FDA Approved: No
Brand name: T-Pred
Generic name: tobramycin and prednisolone
Dosage form: Ophthalmic Suspension
Company: ISTA Pharmaceuticals, Inc.
Treatment for: Ocular Inflammation
Development timeline for T-Pred
Date | Article |
---|---|
May 4, 2007 | ISTA Provides Regulatory Update on T-Pred NDA Filing |
Jul 6, 2006 | ISTA Pharmaceuticals Files NDA for T-Pred |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.